2 news items
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
BMY
IMCR
28 Feb 24
(PFS) by blinded independent central review (BICR), with secondary endpoints of overall survival (OS) and overall response rate (ORR
Earnings Scheduled For February 28, 2024
NOVT
NRG
NSA
28 Feb 24
.
• Independence Contract (NYSE:ICD) is projected to report quarterly loss
- Prev
- 1
- Next